The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Mitrani Maria Ines since 2021.
This trader's CIK number is 1690319.
At the time of last reporting, Mitrani Maria Ines was the Chief Science Officer of Organicell Regenerative Medicine, Inc.. (stock ticker symbol BPSR).
Also see all insider trading activities at Organicell Regenerative Medicine, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2021 | BPSR | 0 | $0 | 1,897,110 | $380,196 | 0 | $0 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2021-06-14 | BPSR | Sale | 50,000 | .14 | 7,000 |
2021-06-15 | BPSR | Sale | 50,000 | .16 | 8,000 |
2021-06-16 | BPSR | Sale | 50,000 | .16 | 8,050 |
2021-06-09 | BPSR | Sale | 80,000 | .15 | 12,160 |
2021-06-10 | BPSR | Sale | 85,200 | .14 | 12,013 |
2021-06-11 | BPSR | Sale | 49,910 | .14 | 6,937 |
2021-06-08 | BPSR | Sale | 100,000 | .13 | 13,400 |
2021-06-07 | BPSR | Sale | 100,000 | .12 | 12,400 |
2021-06-04 | BPSR | Sale | 100,000 | .14 | 13,900 |
2021-06-02 | BPSR | Sale | 90,000 | .16 | 14,760 |
2021-06-01 | BPSR | Sale | 50,000 | .19 | 9,600 |
2021-05-26 | BPSR | Sale | 40,000 | .19 | 7,720 |
2021-05-27 | BPSR | Sale | 100,000 | .18 | 18,000 |
2021-05-28 | BPSR | Sale | 50,000 | .18 | 9,150 |
2021-05-21 | BPSR | Sale | 50,000 | .18 | 9,000 |
2021-05-24 | BPSR | Sale | 50,000 | .18 | 9,000 |
2021-05-25 | BPSR | Sale | 100,000 | .20 | 19,800 |
2021-05-18 | BPSR | Sale | 50,000 | .22 | 11,000 |
2021-05-19 | BPSR | Sale | 102,000 | .23 | 23,256 |
2021-05-20 | BPSR | Sale | 100,000 | .19 | 19,200 |
2021-05-14 | BPSR | Sale | 50,000 | .24 | 12,000 |
2021-05-13 | BPSR | Sale | 50,000 | .27 | 13,500 |
2021-05-17 | BPSR | Sale | 75,000 | .21 | 15,600 |
2021-05-10 | BPSR | Sale | 50,000 | .27 | 13,550 |
2021-05-11 | BPSR | Sale | 75,000 | .32 | 24,300 |
2021-05-12 | BPSR | Sale | 50,000 | .26 | 13,050 |
2021-05-04 | BPSR | Sale | 50,000 | .41 | 20,250 |
2021-04-30 | BPSR | Sale | 50,000 | .47 | 23,600 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mitrani Maria Ines (Chief Science Officer of Organicell Regenerative Medicine, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.